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Abstract
Introduction: Fournier gangrene is a rare necrotising fascitis of the perineum and genitals caused
by a mixture of aerobic and anaerobic microorganisms. The first case was described by Baurienne
in 1764 but the condition was named by Fournier in 1883 who reported the cases of five men with
the condition with no apparent etiology. Infection most commonly arises from the skin, urethra,
or rectal regions. Despite appropriate therapy, mortality in this disease is still high. We report a
case of a low rectal malignancy presenting as Fournier gangrene. This case report serves to highlight
an extremely unusual presentation of rectal cancer, a common surgical pathology.
Case presentation: The patient is a 48 years old Afghanian male that admitted with Fournier
gangrene. In the course of medical and surgical treatment the presence of extensive rectal
adenocarcinoma was discovered. After partial recovery, standard loop colostomy was inserted.
Skin grafting of necrotic areas was performed and systemic rectal cancer chemotherapy initiated
after full stabilization.
Conclusion:  Fournier gangrene is an uncommon but life threatening condition with high
associated mortality and morbidity. Usually there is an underlying cause for the development of
Fournier gangrene, that if addressed correctly, can lead to a good outcome. Early diagnosis and
treatment decrease the morbidity and mortality of this life threatening condition. Good
management is based on aggressive debridement, broad spectrum antibiotics and intensive
supportive care.
Case presentation
The patient is a 48-year-old Afghanian male that referred
to our center due to swelling, redness and tenderness of
external genitalia, that found incidentally in the investiga-
tion of cachexia and weigt loss. He revealed no genitouri-
nary or gastrointestinal complaints before admission.
After admission full physical examination performed.
On examination, patient was cachectic with BMI of 18 kg/
m2. He was afebrile and initial hematological investiga-
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tions revealed only a moderate leucocytosis (WBC count,
18000 Cells/HPF) with mild anemia (Hg 11 g/dl). Exter-
nal genitalia and perianal examination revealed skin
necrosis, pussy drainage and subcutaneous crepitations,
in addition to above mentioned signs.
Urgent and vigorous intravenous triple antibiotic therapy
with Ceftriaxone (2 grams Q 12 h), Metronidazole (500
mg Q 8 h) and Amikacin (500 mg Q 12 h) was com-
menced. He was taken to operating room, multiple times,
and every time vigorous debridement performed. A thor-
ough washout was performed. Following acute manage-
ment a thorough examination including digital rectal
examination was performed which detected an extensive
rectal mass with extension of necrotic points to the anal
area. Punch anal biopsy performed and sent for histolog-
ical analysis, which showed rectal adenocarcinoma. The
zone of necrosis covered a large area from external genital
area to the inner aspect of right thigh to the right side of
the abdomen (Figure 1). A CT scan revealed a large rectal
tumor with pelvic adenopathies. In the course of surgical
management the patient received multiple units of packed
RBC due to intermittent acute bleeding after each surgical
debridement and also anemia of chronic disease-underly-
ing malignancy. He also received regular infusion of
parenteral nutrition. After partial stabilization, a standard
left loop colostomy performed (Figure 1) to prevent an
impending large bowel obstruction and to promote heal-
ing of the perineum. After full stabilization, skin dermal
grafting for full coverage of involved areas performed (Fig-
ure 2).
Systemic chemotherapy for the treatment of underlying
rectal adenocarcinoma initiated, the patient was well one
year after first visit.
Discussion
Fournier gangrene is a rapidly progressive necrotizing fas-
ciitis of the perineum and external genital organs. The first
documented clinical picture of the disease was made by
Fournier in 1883. Its epidemiology has changed and is
much different from the origin. It affecting mostly men
between 50 and 60 years of age. This disease also affects
females. It is uncommon in pediatric age group and little
is known about the disease in the newborn period and
infancy [1]. It is secondary to polymicrobial infection by
aerobic and anaerobic bacteria with a synergistic action.
Candida albicans has also been reported as the primary
microorganism [2]. The most commonly isolated micro-
organism in both male and female patients was E coli [3].
The aetiology is identified in 95% of cases. The source of
infection is either cutaneous, urogenital or colorectal
areas. Predisposing factors, such as age, diabetes, alcohol-
ism, malnutrition, and immunosupression, are often
present in affected patients. In one study Diabetes melli-
tus was the most common associated disease in these
patients, however, it was not related to a statistically sig-
nificant worst prognosis [4]. On the basis of Cakmak
study on the 65 cases the most common etiology was
hemorrhoidectomy in male and perianal abscess in
female patients [3]. In a series of 45 patients with fournier
gangrene, Basoglu et al reported that the most common
etiology was perirectal abscess followed by scrotal carbun-
cle and thrombosed hemorrhoid [5]. This series, which is
among the largest ever published, did not identify color-
ectal carcinoma as an etiology. Korkout et al reported that
the etiology was identifiable in 95% of cases, diabetes
The patient after full recovery and 3 day after colostomy  insertion Figure 1
The patient after full recovery and 3 day after colos-
tomy insertion.
The patient 6 month after skin grafting Figure 2
The patient 6 month after skin grafting.Cases Journal 2009, 2:9136 http://www.casesjournal.com/content/2/1/9136
Page 3 of 4
(page number not for citation purposes)
mellitus being a predisposing factor in 55.6% [6]. Our
patient notably had no such commonly described etiol-
ogy or predisposing factor leading to the conclusion that
gangrenous disease was a manifestation of low rectal can-
cer. A thorough literary review revealed only four reported
cases of Fournier gangrene resulting from colorectal carci-
noma during the last 30 years [7-10]. The carcinomas
described in those reports typically comprised a perforat-
ing adenocarcinoma of the sigmoid colon, leading us to
believe that Fournier gangrene is an extremely unusual
presentation of rectal cancer. Urgent and aggressive treat-
ment is essential to ensure the patients survival. Treatment
consists of restoration the fluid and electrolyte balance
and broad spectrum antibiotic therapy rapidly followed
by surgical debridement. However, the mortality remains
high, about 20 to 80%, frequently, due to delayed diagno-
sis and management. Patients who survive the infection
require reconstructive surgery with sometimes marked
sequelae related to the extent of fasciitis and debridement
[11]. An association between urethral obstruction associ-
ated with strictures and extravasation and instrumenta-
tion has been well documented. Predisposing factors
include diabetes mellitus, local trauma, paraphimosis,
periurethral extravasation of urine, perirectal or perianal
infections, and surgery such as circumcision or hernior-
rhaphy. In cases originating in the genitalia, the infecting
bacteria probably pass through Bucks fascia of the penis
and spread along the dartos fascia of the scrotum and
penis, Colles fascia of the perineum, and scarpas fascia of
the anterior abdominal wall. The Infection commonly
starts as cellulitis. Early on the involved area is swollen,
erythematous, and tender as the infection begins to
involve the deep fascia. Pain is prominent, and fever and
systemic toxicity are marked. Because crepitus is often an
early finding, a plain film of the abdomen may be helpful
in identifying air. The mortality rate averages approxi-
mately 20%, but ranges from 7% to 75%. This is similar
to our in-hospital mortality rate. Higher mortality rates
are found in diabetics, alcoholics, and those with colorec-
tal sources of infection [12].
In a large population based epidemiologic study, 1641
males and 39 females with fournier gangrene identified.
Cases represented less than 0.02% of hospital admissions.
The overall incidence was 1.6/100,000 males, which
peaked in males who were 50 to 79 years old. The overall
case fatality rate was 7.5% [13]. For predicting prognosis,
Fournier gangrene severity index presented [14]. Using a
Fournier gangrene severity index threshold of 9 (sensitiv-
ity 71.4%, specifity 90%) there was a 96% survival rate in
patients with a Fournier gangrene severity index of less
than 9 and a 46% mortality rate in those with a Fournier
gangrene severity index of 9 or greater (p = 0.001, OR
22,95% CI 3.5-139.7) [14].
Conclusion
Necrotizing fascitis of the perineum and genitalia is a
severe condition with a high morbidity and mortality. It
seems that there are no major differences between male
and female patients in the characteristics of the condition
[3]. Good management is based on aggressive debride-
ment, broad spectrum antibiotics and intensive support-
ive care [15]. In the early stages of the disease, before
necrotic lesions occur, a final diagnosis might be difficult.
Hyperbaric oxygen therapy and reconstructive procedures
may be needed in the course of treatment process [16].
The fournier gangrene severity index remains an objective
and simple method to quantify the extent of metabolic
aberration at presentation in patients with founier gan-
grene. A Fournier gangrene severity index threshold value
of 9 is sensitive and specific for predicting mortality in this
patient population [14]. The patients age, the presence of
systemic risk factors, especially cancer, a urological source
of infection and the extent of disease have impact on the
prognosis of Fournier gangrene [4]. Although colorectal
carcinoma has previously been reported as a cause of
Fournier gangrene it remains an extremely rare phenome-
non.
Consent
Written informed consent was obtained from the patient
for publication of this case report and accompanying
images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
MMK is the corresponding author and responsible for the
surgery, SGMA assisted in surgery and editing the manu-
script, MAA and AA were major contributors in writing
and editing the manuscript. All authors read and
approved the final manuscript.
References
1. Ekingen G, Isken T, Agir H, Oncel S: Fourniers gangrene in child-
hood: a report of 3 infant patients.  Journal of Pediatric Surgery
2008, 43(12):e39-42.
2. Temiz M, Cetin M, Aslan A: Fourniers gangrene caused by Can-
dida albicans.  Mikrobiyol Bul 2008, 42(4):707-711.
3. Cakmac A, Genc V, Akyol C, Kayaoglu HA: Fourniers gangrene: is
it scrotal gangrene.  Advanced Therapeutics 2008,
25(10):1065-1074.
4. Medina Polo J, Tejido Sanchez A, de la Rosa Kehrmann F: Fourniers
gangrene: evaluation of prognostic factors in 90 patients.
Actas Urol Esp 2008, 32(10):1024-1030.
5. Basoglu M, Ozbey I, Atamanalp SS, Yildirgan MI, Aydinli B, Polato O,
Ozturk G, Peker K, Onbas O: Management of Fourniers gan-
grene: review of 45 cases.  Surg today 2007, 37(7):558-563.
6. Korkut M, Icoz G, Dayangac M, Akgun E, Yeniay L, Erdogan O, Cal C:
Outcome analysis in patients with Fourniers gangrene:
report of 45 cases.  Dis Clon Rectum 2003, 46(5):649-652.
7. Gould SW, Banwell P, Glazer G: Perforated colonic carcinoma
presenting as epididymo-orchitis and Fourni zers gangrene.
Eur J Surg Oncol 1997, 23(4):367-368.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Cases Journal 2009, 2:9136 http://www.casesjournal.com/content/2/1/9136
Page 4 of 4
(page number not for citation purposes)
8. Flanigan RC, Kursh ED, McDougal WS, Persky L: Synergistic gan-
grene of the scrotum and penis secondary to colorectal dis-
ease.  J Urol 1978, 119(3):369-371.
9. Morpurgo E, Galandiuk S: Fourniers gangrene.  Surg Clin North Am
2002, 82(6):1213-1224.
10. Dewire DM: Carcinoma of the sigmoid colon: an unusual
cause of Fourniers gangrene.  J Urol 1992, 147(3):711-712.
11. Sarkis P, Farran F, Khoury R, Kamel G, Nemr E, Biajini J, Merheje S:
Fourniers gangrene: a review of the recent literature.  Prog
Urol 2009, 19(2):75-84.
12. Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA: Campbell-
Walsh Urology Philadelphia: Elsevier; 2007:301-302. 
13. Sorensen MD, Krieger JN, Rivara FP, Broghammer JA, Klein MB, Mack
CD, Wessells H: Fourniers gangrene: population based epide-
miology and outcomes.  J Urol 2009, 181(5):2120-2126.
14. Corcoran AT, Smaldone MC, Gibbons EP, Walsh TJ, Davies BJ: Vali-
dation of the Fourniers gangrene severity index in a large
contemporary series.  J Urol 2008, 180(3):944-948.
15. Sanchez Mazzaferri F, Fadil Iturralde JL, Provenzal O: Fourniers gan-
grene. Our experience over 10 years. A review of the litera-
ture.  Arch Esp Urol 1999, 52(7):721-727.
16. Zaba R, Grzybowski A, Prokop J, Zaba Z: Fourniers gangrene: his-
torical survey, current status, and case description.  Med Sci
Monit 2009, 15(2):CS34-CS39.